Cargando…

The frequency of assessment of progression in randomized oncology clinical trials

BACKGROUND: Progression in tumor assessments is often detected at a follow‐up appointment rather than when actual change in progression has occurred, which can bias PFS outcomes. AIM: We sought to evaluate the frequency of tumor assessment scans in clinical trials of anti‐cancer interventions and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslam, Alyson, Gill, Jennifer, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327664/
https://www.ncbi.nlm.nih.gov/pubmed/34821077
http://dx.doi.org/10.1002/cnr2.1527